| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 58.814 | 132.618 | 164.405 |
| Total Income - EUR | - | - | - | - | - | - | - | 59.828 | 132.619 | 188.529 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 58.258 | 111.437 | 171.653 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 1.570 | 21.181 | 16.876 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 1.259 | 19.912 | 12.571 |
| Employees | - | - | - | - | - | - | - | 1 | 3 | 4 |
Check the financial reports for the company - Premium Pharmavet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 25.176 | 25.273 | 47.712 |
| Current Assets | - | - | - | - | - | - | - | 48.857 | 59.432 | 110.532 |
| Inventories | - | - | - | - | - | - | - | 47.566 | 49.483 | 91.968 |
| Receivables | - | - | - | - | - | - | - | 0 | 1.263 | 2.534 |
| Cash | - | - | - | - | - | - | - | 1.290 | 8.685 | 16.030 |
| Shareholders Funds | - | - | - | - | - | - | - | 503 | 20.414 | 12.652 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 74.242 | 64.999 | 150.760 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Premium Pharmavet S.r.l.